Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | -0.04 | N/A | N/A | N/A |
2024-02-29 | 2023-12 | -0.04 | N/A | N/A | N/A |
2023-11-01 | 2023-09 | -0.02 | N/A | N/A | N/A |
2023-08-02 | 2023-06 | -0.02 | 0.02 | 0.04 | 200.00% |
2023-05-03 | 2023-03 | -0.01 | 0.02 | 0.03 | 300.00% |
2023-03-01 | 2022-12 | 0.01 | 0.02 | 0.01 | 100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-19 | Goldman Sachs | Upgrade | Sell | Sell |
2023-07-18 | Northland Capital Markets | Upgrade | Market Perform | Market Perform |
2023-01-05 | Jefferies | Upgrade | Hold | Buy |
2022-10-18 | SVB Leerink | Upgrade | Market Perform | |
2022-05-23 | Goldman Sachs | Upgrade | Sell | |
2022-05-05 | JP Morgan | Downgrade | Neutral | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-30 | BERG AARON D. | Officer | 633.26K | Conversion of Exercise of derivative security |
2024-01-21 | HOLT PATRICK | Chief Executive Officer | 314.43K | Purchase |
2022-07-28 | KALB MICHAEL WAYNE | Chief Financial Officer | 337.31K | Conversion of Exercise of derivative security |
2024-01-30 | KETCHUM STEVEN B | Officer | 658.72K | Conversion of Exercise of derivative security |
2022-08-18 | MARKS JASON M | Officer | 21.92K | Conversion of Exercise of derivative security |
2023-02-20 | MIKHAIL KARIM | Chief Executive Officer | 283.51K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Kynam Capital Management, LP | 12.00M | 14.28M | 12.15% |
2023-06-29 | Morgan Stanley | 11.28M | 13.42M | 11.41% |
2023-06-29 | Eversept Partners, LP | 10.50M | 12.50M | 10.63% |
2023-06-29 | Tang Capital Management, LLC | 7.10M | 8.45M | 7.19% |
2023-06-29 | SCP Investment, LP | 6.50M | 7.74M | 6.58% |
2023-06-29 | DG Capital Management, LLC | 5.47M | 6.51M | 5.54% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Northern Lights Fd Tr-13D Activist Fd | 3.81M | 4.53M | 3.85% |
2023-06-29 | Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund | 585.00K | 696.15K | 0.59% |
2023-06-29 | Legg Mason Clearbridge Small Cap Value Fd | 531.07K | 631.97K | 0.54% |
2023-06-29 | Columbia Fds Var Ser Tr II-Columbia Var Port-Overseas Core Fd | 458.93K | 546.12K | 0.46% |
2023-05-30 | Columbia Fds Ser Tr-Columbia Overseas Value Fd | 315.88K | 369.58K | 0.32% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 214.39K | 250.83K | 0.22% |
Split | Date |
---|---|
0.1 : 1 | 2008-01-18 |
0.1 : 1 | 1998-10-19 |
-
This will go down over the next week. Massive short sell off coming.
-
-
June 10th is the drop dead date. 2 weeks from yesterday. Why speculate and drive yourselves nuts over it?
-
Najarian - calls for Amarin
https://www.cnbc.com/video/2019/05/24/options-traders-say-its-hip-to-be-square.html
-
What is going on with some of you people? Today I believe is day 61. Doesn’t the FDA have 60-74 days to respond?
-
Anyone hear work for Amarin? If not.....shut your pie hole. NOT 1 PERSON KNOWS WHAT THE FDA, AMARIN, JT OR THE DOW WILL DO.
-
-
Stop guessing. Not one of you idiots (bears or bulls) work for the FDA or know what the FDA will decide on a priority review. Give it a rest!
-
Just need to keep an eye on the trade talks. Tariffs on “ALL” Chinese goods could send the market into a tail spin. Add in 1 missile test near Iran and label expansion won’t matter
-
AMRN all the way
-
Geronimo
-
Is there a chance of priority review but a rejection of label expansion? I would imagine priority review almost certainly guarantees an approved label expansion
-
I need Dramamine
-
Good script numbers won’t matter. Tariffs and MMs are in full control
-
I love it when bears come out of the woodwork and preach doom and gloom. It means a new high is just around the corner because they are always wrong in the long run
-
Amarin is a tad cheaper
-
PFE is hovering around $41.72. How could they pay more pps for Amarin than their own stock is worth? Educate me.....I keep seeing crazy numbers from $51pps-$120pps.
-
-
So.....$16.50 today? Gotta love tariffs
-
Amarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcript
seekingalpha.com • -
Amarin: Sarissa Is Giving Me Hope Again
seekingalpha.com • -
Why Amarin Stock Skyrocketed Today
fool.com • -
Amarin stock soars on preliminary 4Q revenue guidance, share buyback plan
proactiveinvestors.com • -
Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
What Makes Amarin (AMRN) a New Buy Stock
zacks.com • -
Soleno Therapeutics: Impressive Data, But Never Forget Amarin
seekingalpha.com • -
Amarin to Present at the 2023 Cantor Global Healthcare Conference
globenewswire.com • -
10 Top Penny Stocks To Buy According To Insiders In August
pennystocks.com • -
Amarin: New Management, But No Radical Changes To Strategy, Or Outlook
seekingalpha.com • -
Amarin to Present at Two Upcoming Investor Conferences
globenewswire.com • -
Amarin: Sarissa Has Control, But Amarin Will Need Patience
seekingalpha.com • -
Penny Stocks To Buy: 5 To Watch Before Next Week
pennystocks.com • -
Amarin Corporation plc (AMRN) Q4 2022 Earnings Call Transcript
seekingalpha.com • -
Positive Events Are Lining Up At Amarin
seekingalpha.com • -
Amarin to Present at Cowen's 43rd Annual Health Care Conference
globenewswire.com • -
Amarin Shareholders Invited to Webcast with Board and Management Team
globenewswire.com • -
Amarin to Present at SVB Securities Global Biopharma Conference
globenewswire.com • -
Why Amarin Stock Tumbled This Week
fool.com • -
3 Penny Stocks to Sell in January Before They Peter Out
investorplace.com • -
Amarin's stock is up 17% on strong revenue estimates for 2022
marketwatch.com • -
Penny Stocks To Buy In 2023? 3 To Watch In January
pennystocks.com • -
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
Why Amarin (AMRN) Stock Might be a Great Pick
zacks.com • -
Why Amarin Stock Was a Winner Today
fool.com • -
Amarin to Present at Jefferies London Healthcare Conference
globenewswire.com • -
Amarin Corporation plc (AMRN) Q3 2022 Results - Earnings Call Transcript
seekingalpha.com • -
Amarin to Present at H.C. Wainwright's 24th Annual Global Investment Conference
globenewswire.com • -
Why Amarin Stock Was Plunging This Week
fool.com • -
7 F-Rated Growth Stocks to Sell Before Q4
investorplace.com • -
Are Ocugen or Amarin Good Penny Stocks to Buy?
marketbeat.com • -
For Amarin, Something Wishful This Way Comes
seekingalpha.com • -
Does Amarin Deserve a Spot in Your Portfolio after Earnings?
marketbeat.com • -
4 Best Penny Stocks To Buy On Reddit According To Options Traders
pennystocks.com • -
Why Amarin Stock Dipped This Week
fool.com • -
July Penny Stocks Buying Guide, 3 Things to Know
pennystocks.com • -
Why Amarin Stock Is Sinking Today
fool.com • -
Penny Stocks To Buy Now? 4 To Watch With Big News
pennystocks.com • -
Why Amarin Stock Blasted Higher on Friday
fool.com • -
4 Hot Penny Stocks With News To Watch Right Now
pennystocks.com • -
New Strong Sell Stocks for May 13th
zacks.com • -
Why Amarin Shares Are Plunging After Q1 Earnings
benzinga.com • -
Amarin Corp.: Hitting The Thesis Reset Button
seekingalpha.com • -
Amarin: Alex Denner, Health Net, Statin Combo, And Signs Of Better Times
seekingalpha.com • -
3 Penny Stocks to Add to Your Watchlist This Week
pennystocks.com • -
Should These Penny Stocks Be On Your February Watchlist?
pennystocks.com • -
These Hot Penny Stocks Are Climbing While the Stock Market is Down
pennystocks.com • -
Amarin to Present at the 40th Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
Are These Penny Stocks Worth Buying Right Now Or Not?
pennystocks.com • -
Amarin Stock: Sales From China And Europe May Make The Price Spike Up
seekingalpha.com • -
Here's 3 Penny Stocks You Need to Know About Today
pennystocks.com •